期刊
STEROIDS
卷 78, 期 1, 页码 44-52出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2012.10.008
关键词
Methyltestosterone; Sulphate; Metabolism; LC-MS/MS; Doping analysis
资金
- World Anti-Doping Agency WADA [09A20RV]
- Consejo Superior de Deportes (Ministerio de la Presidencia, Gobierno de Espana) [010/SAL10/11]
- Consell Catala de l'Esport and Departament d'Innovacio, Universitats i Empresa, DIUE [SGR 492]
- Instituto de Salud Carlos III
Methyltestosterone (MT) is one of the most frequently detected anabolic androgenic steroids in doping control analysis. MT misuse is commonly detected by the identification of its two main metabolites excreted as glucuronide conjugates, 17 alpha-methyl-5 alpha-androstan-3 alpha,17 beta-diol and 17 alpha-methyl-5 beta-androstan-3 alpha,17 beta-diol. The detection of these metabolites is normally performed by gas chromatography-mass spectrometry, after previous hydrolysis with beta-glucuronidase enzymes, extraction and derivatization steps. The aim of the present work was to study the sulphate fraction of MT and to evaluate their potential to improve the detection of the misuse of the drug in sports. MT was administered to healthy volunteers and urine samples were collected up to 30 days after administration. After an extraction with ethyl acetate, urine extracts were analysed by liquid chromatography tandem mass spectrometry using electrospray ionisation in negative mode by monitoring the transition m/z 385 to m/z 97. Three diol sulphate metabolites (S1, S2 and S3) were detected. Potential structures for these metabolites were proposed after solvolysis and mass spectrometric experiments: S1, 17 alpha-methyl-5 beta-androstan-3 alpha,17 beta-diol 3 alpha-sulphate; S2, 17 beta-methyl-5 alpha-androstan-3 alpha,17 alpha-diol 3 alpha-sulphate; and S3, 17 beta-methyl-5 beta-androstan-3 alpha,17 alpha-diol 3 alpha-sulphate. Synthesis of reference compounds will be required in order to confirm the structures. The retrospectivity of these sulphate metabolites in the detection of MT misuse was compared with the obtained with previously described metabolites. Metabolite S2 was detected up to 21 days after MT administration, improving between 2 and 3 times the retrospectivity of the detection compared to the last long-term metabolite of MT previously described, 17 alpha-hydroxy-17 beta-methylandrostan-4,6-dien-3-one. (c) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据